Promoting successful cognitive aging: A comprehensive review

Journal of Alzheimer's Disease

Volumn 19, Issue 4, 2010, Pages 1101-1122

  Daffner, Kirk R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical research methods; Cognition; Cognitive reserve; Dementia risk factors; Neuroprotection; Successful aging

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ATENOLOL; CEREBROLYSIN; CHLORTALIDONE; CHOLINESTERASE INHIBITOR; CITICOLINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIHYDROERGOTOXINE MESILATE; DOCOSAHEXAENOIC ACID; ENALAPRIL; FISH OIL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; LEVACECARNINE; MODAFINIL; NITRENDIPINE; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PIRACETAM; RESERPINE; RESVERATROL; SELEGILINE; UNINDEXED DRUG; VINPOCETINE; VITAMIN B COMPLEX;

AGING; CARDIOVASCULAR RISK; CLINICAL RESEARCH; COGNITION; DEMENTIA; DIABETES MELLITUS; GINKGO BILOBA; GINSENG; HUMAN; INFORMATION PROCESSING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP DISORDER;

EID: 77950360683     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1306     Document Type: Review

References (210)

1. Department of Economic and Social Affairs PD (2007)World Population Ageing, United Nations Publications, New York.
2. Commissaris CJ, Ponds RW, Jolles J (1998) Subjective forgetfulness in a normal Dutch population: possibilities for health education and other interventions. Patient Educ Couns 34, 25-32.
3. Ponds RW, Commissaris KJ, Jolles J (1997) Prevalence and covariates of subjective forgetfulness in a normal population in The Netherlands. Int J Aging Hum Dev 45, 207-221.
4. Bassett SS, Folstein MF (1993) Memory complaint, memory performance, and psychiatric diagnosis: a community study. J Geriatr Psychiatry Neurol 6, 105-111.
5. Alzheimer's Association (2007) Alzheimer's disease facts and figures. http://www.alz.org/national/documents/Report 2007FactsAndFigures.pdf Last updated 2007, Accessed on August 31, 2009.
6. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, ChownMJ, Hebert LE, Hennekens CH,Taylor JO (1989) Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262, 2551-2556.
7. Hy LX, Keller DM (2000) Prevalence of AD among whites: a summary by levels of severity. Neurology 55, 198-204.
8. Morris JC, Storandt M, McKeel DW, Jr., Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46, 707-719.
9. Drachman DA (2006) Aging of the brain, entropy, and Alzheimer disease. Neurology 67, 1340-1352.
10. Thal DR, Del Tredici K, Braak H (2004) Neurodegeneration in normal brain aging and disease. Sci Aging Knowledge Environ 2004, e26.
11. Kramer JH, Mungas D, Reed BR, Wetzel ME, Burnett MM, Miller BL, Weiner MW, Chui HC (2007) Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 21, 412-418.
12. Rowe JW, Kahn RL (1987) Human aging: usual and successful. Science 237, 143-149.
13. Whalley LJ, Deary IJ, Appleton CL, Starr JM (2004) Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev 3, 369-382.
14. Hipkiss AR (2006) Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol 41, 464-473.
15. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, Eckert A, Muller WE (2007) Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal 9, 1659-1675.
16. Morgan TE,Wong AM, Finch CE (2007) Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. Interdiscip Top Gerontol 35, 83-97.
17. Terman A, Gustafsson B, Brunk UT (2006) Mitochondrial damage and intralysosomal degradation in cellular aging. Mol Aspects Med 27, 471-482.
18. Tosato M, Zamboni V, Ferrini A, Cesari M(2007) The aging process and potential interventions to extend life expectancy. Clin Interv Aging 2, 401-412.
19. Lindenberger U, Baltes PB (1994) Sensory functioning and intelligence in old age: a strong connection. Psychol Aging 9, 339-355.
20. Lindenberger U, Scherer H, Baltes PB (2001) The strong connection between sensory and cognitive performance in old age: not due to sensory acuity reductions operating during cognitive assessment. Psychol Aging 16, 196-205.
21. Baltes PB, Lindenberger U (1997) Emergence of a powerful connection between sensory and cognitive functions across the adult life span: a new window to the study of cognitive aging? Psychol Aging 12, 12-21.
22. Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, Loken WJ, Thornton AE, Acker JD (1997) Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex 7, 268-282.
23. Salthouse TA (1996) The processing-speed theory of adult age differences in cognition. Psychol Rev 103, 403-428.
24. Van Petten C, Plante E, Davidson PS, Kuo TY, Bajuscak L, Glisky EL (2004) Memory and executive function in older adults: relationships with temporal and prefrontal gray matter volumes and white matter hyperintensities. Neuropsychologia 42, 1313-1335.
25. Jernigan TL, Archibald SL, Berhow MT, Sowell ER, Foster DS, Hesselink JR (1991) Cerebral structure on MRI, Part I: Localization of age-related changes. Biol Psychiatry 29, 55-67.
26. Charlton RA, Barrick TR, McIntyre DJ, Shen Y, O'Sullivan M, Howe FA, Clark CA, Morris RG, Markus HS (2006) White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 66, 217-222.
27. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Hitzemann R, Smith G, Fields SD, Gur R (1996) Dopamine transporters decrease with age. J Nucl Med 37, 554-559.
28. Volkow ND, Gur RC,Wang GJ, Fowler JS, Moberg PJ, Ding Y-S, Hitzemann R, Smith G, Logan J (1998) Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 155, 344-349.
29. Perls T (2004) Dementia-free centenarians. Exp Gerontol 39, 1587-1593.
30. Jofre-Monseny L, Minihane AM, Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52, 131-145.
31. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA, Plomin R (1997) Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 276, 1560-1563.
32. Mahley RW, Huang Y, Weisgraber KH (2007) Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 4, 537-540.
33. Espeseth T, Greenwood PM, Reinvang I, Fjell AM, Walhovd KB, Westlye LT, Wehling E, Lundervold A, Rootwelt H, Parasuraman R (2006) Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cogn Affect Behav Neurosci 6, 31-43.
34. Small BJ, Rosnick CB, Fratiglioni L, Backman L (2004) Apolipoprotein E and cognitive performance: a metaanalysis. Psychol Aging 19, 592-600.
35. Fraser GE, Shavlik DJ (2001) Ten years of life: Is it a matter of choice? Arch Intern Med 161, 1645-1652.
36. Stern Y (2006) Cognitive Reserve Theory and Application, Psychology Press, New York.
37. Bertoni-Freddari C, Fattoretti P, Casoli T, Di Stefano G, Giorgetti B, Balietti M (2008) Brain aging: The zinc connection. Exp Gerontol 43, 389-393.
38. Lindenberger U, Baltes PB (1997) Intellectual functioning in old and very old age: cross-sectional results from the Berlin Aging Study. Psychol Aging 12, 410-432.
39. Satz P (1993) Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 7, 273-295.
40. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817.
41. Cechetto DF, Hachinski V, Whitehead SN (2008) Vascular risk factors and Alzheimer's disease. Expert Rev Neurother 8, 743-750.
42. Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS (2008) Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc 56, 2076-2081.
43. Weaver TE, Chasens ER (2007) Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev 11, 99-111.
44. Ancoli-Israel S, Ayalon L (2006) Diagnosis and treatment of sleep disorders in older adults. Am J Geriatr Psychiatry 14, 95-103.
45. Tsao J, Shah R, Leurgens S, Wilson R, Janos A, Wei P, Bennett D, Heilman K (2008) Impaired cognition in normal individuals using medications with anticholinergic activity occurs following several years. 2008 AAN Meeting Program A, 418.
46. Coffey CE, Saxton JA, RatcliffG, Bryan RN, Lucke JF (1999) Relation of education to brain size in normal aging: implications for the reserve hypothesis. Neurology 53, 189-196.
47. Lee S, Kawachi I, Berkman LF, Grodstein F (2003) Education, other socioeconomic indicators, and cognitive function. Am J Epidemiol 157, 712-720.
48. Scarmeas N, Zarahn E, Anderson KE, Hilton J, Flynn J, Van Heertum RL, Sackeim HA, Stern Y (2003) Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. NeuroImage 19, 1215-1227.
49. Schmand B, Smit JH, Geerlings MI, Lindeboom J (1997) The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis. Psychol Med 27, 1337-1344.
50. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (1994) Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271, 1004-1010.
51. Stern Y, Alexander GE, Prohovnik I, Mayeux R (1992) Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 32, 371-375.
52. Stern Y, Alexander GE, Prohovnik I, Stricks L, Link B, Lennon MC, Mayeux R (1995) Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology 45, 55-60.
53. Potter GG, Helms MJ, Plassman BL (2008) Associations of job demands and intelligence with cognitive performance among men in late life. Neurology 70, 1803-1808.
54. Ngandu T, von Strauss E, Helkala EL, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Education and dementia: what lies behind the association? Neurology 69, 1442-1450.
55. Katzman R (1993) Education and the prevalence of dementia and Alzheimer's disease. Neurology 43, 13-20.
56. BennettDA,Wilson RS, Schneider JA, EvansDA, Mendes de LeonCF, Arnold SE, Barnes LL, Bienias JL (2003) Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60, 1909-1915.
57. Raymont V, Greathouse A, Reding K, Lipsky R, Salazar A, Grafman J (2008) Demographic, structural and genetic predictors of late cognitive decline after penetrating head injury. Brain 131, 543-558.
58. Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, Viitanen M, Parkkola R, Rinne JO (2008) Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 63, 112-118.
59. Roe CM, Mintun MA, D'Angelo G, Xiong C, Grant EA, Morris JC (2008) Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol 65, 1467-1471.
60. Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, Marder KS, Bell KL, Sackeim HA,Van Heertum RL, Moeller JR, Stern Y (2003) Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 60, 359-365.
61. Carlson MC, Zandi PP, Plassman BL, Tschanz JT, Welsh- Bohmer KA, Steffens DC, Bastian LA, Mehta KM, Breitner JC (2001) Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study. Neurology 57, 2210-2216.
62. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521.
63. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2947-2958.
64. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2959-2968.
65. Kang JH,Weuve J, Grodstein F (2004) Postmenopausal hormone therapy and risk of cognitive decline in communitydwelling aging women. Neurology 63, 101-107.
66. Scharf JM, Daffner KR (2007) NSAIDs in the prevention of dementia: a Cache-22? Neurology 69, 235-236.
67. Barnes DE, Yaffe K, Satariano WA, Tager IB (2003) A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc 51, 459-465.
68. Colcombe S, Kramer AF (2003) Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 14, 125-130.
69. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P,KukullW(2006) Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 144, 73-81.
70. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K (2001) Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58, 498-504.
71. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F (2004) Physical activity, including walking, and cognitive function in older women. JAMA 292, 1454-1461.
72. Albert MS, Jones K, Savage CR, Berkman L, Seeman T, Blazer D, Rowe JW (1995) Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging 10, 578-589.
73. Scarmeas N, Luchsinger J, Schupf N, Brickman AM, Cosentino S,Tang MX, Stern Y (2009) Physical activity, diet, and risk of Alzheimer's disease. JAMA 302, 627-637.
74. Yaffe K, Fiocco AJ, Lindquist K, Vittinghoff E, Simonsick EM, Newman AB, Satterfield S, Rosano C, Rubin SM, Ayonayon HN, Harris TB (2009) Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology 72, 2029-2035.
75. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H (2004) Walking and dementia in physically capable elderly men. JAMA 292, 1447-1453.
76. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M (2005) Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 4, 705-711.
77. Abbott RD, Rodriguez BL, Burchfiel CM, Curb JD (1994) Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. Am J Epidemiol 139, 881-893.
78. Fillit H, Nash DT, Rundek T, Zuckerman A (2008) Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother 6, 100-118.
79. Daffner KR, Ryan KK, Williams DM, Budson AE, Rentz DM, Scinto LFM, Holcomb PJ (2005) Age-related differences in novelty and target processing among cognitively high performing adults. Neurobiol Aging 26, 1123-1295.
80. Daffner KR, Ryan KK, Williams DM, Budson AE, Rentz DM,Wolk DA, Holcomb PJ (2006) Increased responsiveness to novelty is associated with successful cognitive aging. J Cogn Neurosci 18, 1759-1773.
81. Daffner KR, Chong H, Riis J, Rentz DM,Wolk DA, Budson AE, Holcomb PJ (2007) Cognitive status impacts age-related changes in attention to novel and target events in normal adults. Neuropsychology 21, 291-300.
82. Riis JL, Chong H, Ryan KK, Wolk DA, Rentz DM, Holcomb PJ, Daffner KR (2008) Compensatory neural activity distinguishes different patterns of normal cognitive aging. NeuroImage 39, 441-454.
83. Swan GE, Carmelli D (1996) Curiosity and mortality in aging adults: a 5-year follow-up of the Western Collaborative Group Study. Psychol Aging 11, 449-453.
84. Wilson RS, Bennett DA, Bienias JL, Aggarwal NT, Mendes de Leon CF, Morris MC, Schneider JA, Evans DA (2002) Cognitive activity and incident AD in a population-based sample of older persons. Neurology 59, 1910-1914.
85. Wilson RS, Mendes de Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 287, 742-748.
86. Verghese J, Levalley A, Derby C, Kuslansky G, Katz M, Hall C, Buschke H, Lipton RB (2006) Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology 66, 821-827.
87. Wang HX, Karp A,Winblad B, Fratiglioni L (2002) Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol 155, 1081-1087.
88. Carlson MC, Helms MJ, Steffens DC, Burke JR, Potter GG, Plassman BL (2008) Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement 4, 324-331.
89. Friedland RP, Fritsch T, Smyth KA, Koss E, Lerner AJ, Chen CH, Petot GJ, Debanne SM (2001) Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci U S A 98, 3440-3445.
90. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 355, 1315-1319.
91. Kang JH, Cook N, Manson J, Buring JE, Grodstein F (2006) A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 166, 2462-2468.
92. Ertel KA, Glymour MM, Berkman LF (2008) Effects of social integration on preserving memory function in a nationally representative US elderly population. Am J Public Health 98, 1215-1220.
93. Willcox BJ, He Q, Chen R, Yano K, Masaki KH, Grove JS, Donlon TA,Willcox DC, Curb JD (2006) Midlife risk factors and healthy survival in men. JAMA 296, 2343-2350.
94. Barnes DE, Cauley JA, Lui LY, Fink HA, McCulloch C, Stone KL, Yaffe K (2007) Women who maintain optimal cognitive function into old age. J Am Geriatr Soc 55, 259-264.
95. Launer LJ, RossGW, Petrovitch H, Masaki K, FoleyD, White LR, Havlik RJ (2000) Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21, 49-55.
96. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ (2000) Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging 21, 57-62.
97. Haag MD, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH (2009) Duration of antihypertensive drug use and risk of dementia: A prospective cohort study. Neurology 72, 1727-1734.
98. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW (2007) Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30, 2655-2660.
99. Yaffe K (2007) Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 21, 167-171.
100. Yaffe K (2007) Metabolic syndrome and cognitive decline. Curr Alzheimer Res 4, 123-126.
101. Whitmer RA, Gunderson EP, Quesenberry CP, Jr., Zhou J, Yaffe K (2007) Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 4, 103-109.
102. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057-1064.
103. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277-281.
104. Dufouil C, Richard F, Fievet N, Dartigues JF, Ritchie K, Tzourio C, Amouyel P, Alperovitch A (2005) APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 64, 1531-1538.
105. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17, 14-20.
106. Mainous AG, Eschenbach SL,Wells BJ, Everett CJ, Gill JM (2005) Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort. Fam Med 37, 36-42.
107. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137, 149-155.
108. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB,Wolf PA (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 163, 1053-1057.
109. Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD (2008) Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 71, 344-350.
110. Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM (2009) Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 80, 13-17.
111. Sparks DL, Kryscio RJ, Sabbagh MN, Connor DJ, Sparks LM, Liebsack C (2008) Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res 5, 416-421.
112. Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF,EvansDA, BennettDA(2008) Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 70, 1795-1802.
113. Li G, Higdon R, Kukull WA, Peskind E, Van Valen MK, Tsuang D, van Belle G, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB (2004) Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 63, 1624-1628.
114. Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC (2005) Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry 62, 217-224.
115. Luchsinger JA, Mayeux R (2004) Dietary factors and Alzheimer's disease. Lancet Neurol 3, 579-587.
116. Balk E, Chung M, Raman G, Tatsioni A, Chew P, Ip S, DeVine D, Lau J (2006) B vitamins and berries and agerelated neurodegenerative disorders. Evid Rep Technol Assess (Full Rep), 1-161.
117. Morris MC, Evans DA, Tangney CC, Bienias JL,Wilson RS (2006) Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 67, 1370-1376.
118. Roman B, Carta L, Martinez-Gonzalez MA, Serra-Majem L (2008) Effectiveness of the Mediterranean diet in the elderly. Clin Interv Aging 3, 97-109.
119. Van Dyk K, Sano M (2007) The impact of nutrition on cognition in the elderly. Neurochem Res 32, 893-904.
120. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA (2006) Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59, 912-921.
121. Knopman DS (2009) Mediterranean diet and late-life cognitive impairment. JAMA 302, 686-687.
122. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA (2009) Mediterranean diet and mild cognitive impairment. Arch Neurol 66, 216-225.
123. Ruitenberg A, van Swieten JC, Witteman JC, Mehta KM, van Duijn CM, Hofman A, Breteler MM (2002) Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359, 281-286.
124. Peters R, Peters J, Warner J, Beckett N, Bulpitt C (2008) Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37, 505-512.
125. Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Baldassarre G, Scapicchio P, Scafato E, Amodio M, Capurso A, Panza F (2007) Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology 68, 1790-1799.
126. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, Breteler MB (1997) Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 153, 185-192.
127. Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R (2004) Alcohol intake and risk of dementia. J Am Geriatr Soc 52, 540-546.
128. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156, 445-453.
129. Broustet JP (1999) Wine and health. Heart 81, 459-460.
130. Letenneur L (2004) Risk of dementia and alcohol and wine consumption: a review of recent results. Biol Res 37, 189-193.
131. Knutson MD, Leeuwenburgh C (2008) Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr Rev 66, 591-596.
132. Pirola L, Frojdo S (2008) Resveratrol: one molecule, many targets. IUBMB Life 60, 323-332.
133. Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020-1035.
134. Hillman CH, Erickson KI, Kramer AF (2008) Be smart, exercise your heart: exercise effects on brain and cognition. Nat Rev Neurosci 9, 58-65.
135. Churchill JD, Galvez R, Colcombe S, Swain RA, Kramer AF, Greenough WT (2002) Exercise, experience and the aging brain. Neurobiol Aging 23, 941-955.
136. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW (1996) Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726, 49-56.
137. Fan Y, Liu Z, Weinstein PR, Fike JR, Liu J (2007) Environmental enrichment enhances neurogenesis and improves functional outcome after cranial irradiation. Eur J Neurosci 25, 38-46.
138. Albert MS (2007) Changing the trajectory of cognitive decline? N Engl J Med 357, 502-503.
139. Connor JR, Melone JH, Yuen AR, Diamond MC(1981) Dendritic length in aged rats' occipital cortex: an environmentally induced response. Exp Neurol 73, 827-830.
140. Kempermann G,Kuhn HG, GageFH(1997)More hippocampus neurons in adult mice living in an enriched environment. Nature 386, 493-495.
141. van Praag H, Kempermann G, Gage FH (2000) Neural consequences of environmental enrichment. Nat Rev Neurosci 1, 191-198.
142. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade- Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120, 701-713.
143. Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai LH (2007) Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178-182.
144. Miida T, Takahashi A, Ikeuchi T (2007) Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther 113, 378-393.
145. Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L (2007) Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist 13, 208-213.
146. Schmeer C, Kretz A, Isenmann S (2006) Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins. Restor Neurol Neurosci 24, 79-95.
147. Menge T, Hartung HP, Stuve O (2005) Statins-a cure-all for the brain? Nat Rev Neurosci 6, 325-331.
148. Florent-Bechard S, Malaplate-Armand C, Koziel V, Kriem B, Olivier JL, Pillot T, Oster T (2007) Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects. J Neurol Sci 262, 27-36.
149. Lukiw WJ, Bazan NG (2008) Docosahexaenoic acid and the aging brain. J Nutr 138, 2510-2514.
150. Orr SK, Bazinet RP (2008) The emerging role of docosahexaenoic acid in neuroinflammation. Curr Opin Investig Drugs 9, 735-743.
151. Jiang WJ (2008) Sirtuins: novel targets for metabolic disease in drug development. Biochem Biophys Res Commun 373, 341-344.
152. Anekonda TS (2006) Resveratrol-a boon for treating Alzheimer's disease? Brain Res Rev 52, 316-326.
153. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
154. Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280, 37377-37382.
155. Ponto LL, Schultz SK (2003) Ginkgo biloba extract: review of CNS effects. Ann Clin Psychiatry 15, 109-119.
156. Yoshikawa T, Naito Y, Kondo M (1999) Ginkgo biloba leaf extract: reviewof biological actions and clinical applications. Antioxid Redox Signal 1, 469-480.
157. Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE (2000) Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 81, 668-678.
158. Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, Khan I, Netzer WJ, Xu H, Butko P (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A 99, 12197-12202.
159. Marks BL, Madden DJ, Bucur B, Provenzale JM, White LE, Cabeza R, Huettel SA (2007) Role of aerobic fitness and aging on cerebral white matter integrity. Ann N Y Acad Sci 1097, 171-174.
160. Deary IJ, Bastin ME, Pattie A, Clayden JD, Whalley LJ, Starr JM,Wardlaw JM(2006) White matter integrity and cognition in childhood and old age. Neurology 66, 505-512.
161. Gunning-Dixon FM, Raz N (2000) The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 14, 224-232.
162. Pantoni L, Poggesi A, Inzitari D (2007) The relation between white-matter lesions and cognition. Curr Opin Neurol 20, 390-397.
163. Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, May A (2004) Neuroplasticity: changes in grey matter induced by training. Nature 427, 311-312.
164. Maguire EA, Gadian DG, Johnsrude IS, Good CD, Ashburner J, Frackowiak RS, Frith CD (2000) Navigation-related structural change in the hippocampi of taxi drivers. Proc Natl Acad Sci U S A 97, 4398-4403.
165. Fjell AM, Walhovd KB, Reinvang I, Lundervold A, Salat D, Quinn BT, Fischl B, Dale AM (2005) Selective increase of cortical thickness in high-performing elderly-structural indices of optimal cognitive aging. NeuroImage 29, 984-994.
166. McNab F, Varrone A, Farde L, Jucaite A, Bystritsky P, Forssberg H, Klingberg T (2009) Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science 323, 800-802.
167. Erickson KI, Colcombe SJ, Wadhwa R, Bherer L, Peterson MS, Scalf PE, Kim JS, Alvarado M, Kramer AF (2006) Training-induced plasticity in older adults: Effects of training on hemispheric asymmetry. Neurobiol Aging 28, 272-283.
168. Logan JM, Sanders AL, Snyder AZ, Morris JC, Buckner RL (2002) Under-recruitment and nonselective recruitment: dissociable neural mechanisms associated with aging. Neuron 33, 827-840.
169. Ghisletta P, de Ribaupierre A (2005) A dynamic investigation of cognitive dedifferentiation with control for retest: evidence from the Swiss Interdisciplinary Longitudinal Study on the Oldest Old. Psychol Aging 20, 671-682.
170. Cabeza R, Anderson ND, Locantore JK, McIntoshAR(2002) Aging gracefully: compensatory brain activity in highperforming older adults. NeuroImage 17, 1394-1402.
171. Reuter-Lorenz PA, Jonides J, Smith EE, Hartley A, Miller A, Marshuetz C, Koeppe RA (2000) Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci 12, 174-187.
172. Rosen AC, Prull MW, O'Hara R, Race EA, Desmond JE, Glover GH, Yesavage JA, Gabrieli JD (2002) Variable effects of aging on frontal lobe contributions to memory. NeuroReport 13, 2425-2428.
173. Rypma B, D'Esposito M (2000) Isolating the neural mechanisms of age-related changes in human working memory. Nat Neurosci 3, 509-515.
174. Colcombe SJ, Kramer AF, Erickson KI, Scalf P (2005) The implications of cortical recruitment and brain morphology for individual differences in inhibitory function in aging humans. Psychol Aging 20, 363-375.
175. Nielson KA, Langenecker SA, Garavan H(2002) Differences in the functional neuroanatomy of inhibitory control across the adult life span. Psychol Aging 17, 56-71.
176. Polich J, Lardon MT (1997) P300 and long-term physical exercise. Electroencephalogr Clin Neurophysiol 103, 493-498.
177. McDowell K, Kerick SE, Santa Maria DL, Hatfield BD (2003) Aging, physical activity, and cognitive processing: an examination of P300. Neurobiol Aging 24, 597-606.
178. Daffner KR, Ryan KK, Williams DM, Budson AE, Rentz DM, Wolk DA, Holcomb PJ (2006) Age-related differences in attention to novelty among cognitively high performing adults. Biol Psychol 72, 67-77.
179. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L (2008) Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev CD005381.
180. Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF (2006) Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci 61, 1166-1170.
181. Colcombe SJ, Kramer AF, Erickson KI, Scalf P, McAuley E, Cohen NJ, Webb A, Jerome GJ, Marquez DX, Elavsky S (2004) Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci U S A 101, 3316-3321.
182. Ball K, Berch DB, Helmers KF, Jobe JB, Leveck MD, Marsiske M, Morris JN, Rebok GW, Smith DM, Tennstedt SL, Unverzagt FW, Willis SL (2002) Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 288, 2271-2281.
183. Willis SL, Tennstedt SL, MarsiskeM, Ball K, Elias J,Koepke KM, Morris JN, Rebok GW, Unverzagt FW, Stoddard AM, Wright E (2006) Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 296, 2805-2814.
184. Wolinsky FD, Unverzagt FW, Smith DM, Jones R, Stoddard A, Tennstedt SL (2006) The ACTIVE cognitive training trial and health-related quality of life: protection that lasts for 5 years. J Gerontol A Biol Sci Med Sci 61, 1324-1329.
185. Mahncke HW, Connor BB, Appelman J, Ahsanuddin ON, Hardy JL, Wood RA, Joyce NM, Boniske T, Atkins SM, Merzenich MM(2006) Memory enhancement in healthy older adults using a brain plasticity-based training program: A randomized, controlled study. Proc Natl Acad Sci U S A 103, 12523-12528.
186. Smith GE, Housen P, Yaffe K, Ruff R, Kennison RF, Mahncke HW, Zelinski EM (2009) A Cognitive Training Program Based on Principles of Brain Plasticity: Results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) Study. J Am Geriatr Soc 57, 594-603.
187. Poon IO (2008) Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Pharmacotherapy 28, 366-375.
188. McGuinness B, Todd S, Passmore P, Bullock R (2006) The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev CD004034.
189. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351.
190. PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358, 1033-1041.
191. Tzourio C, Anderson C, Chapman N,Woodward M, Neal B, MacMahon S, Chalmers J (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163, 1069-1075.
192. Probstfield JL, Applegate WB, Borhani NO, Curb JD, Cutler JA, Davis BR, Furberg CD, Hawkins CM, Lakatos E, Page LB, et al. (1989) The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group. Clin Exp Hypertens A 11, 973-989.
193. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265, 3255-3264.
194. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A (2003) The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21, 875-886.
195. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360, 1623-1630.
196. Heart Protection Study Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet 360, 7-22.
197. Parale GP, Baheti NN, Kulkarni PM, Panchal NV (2006) Effects of atorvastatin on higher functions. Eur J Clin Pharmacol 62, 259-265.
198. Yaffe K (2007) Antioxidants and prevention of cognitive decline: does duration of use matter? Arch Intern Med 167, 2167-2168.
199. Lim WS, Gammack JK, Van Niekerk J, Dangour AD (2006) Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev CD005379.
200. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, de Groot CP (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71, 430-438.
201. Global Nutrition Sciences (2009) Red wine's amazing secret, revealed! http://www.gns-online.com/resv/rx10im/, Last updated 2009, Accessed on August 13, 2009.
202. Karr V (2009) The fountain of youth has been discovered through Resveratrol Anti- aging! http://oolongteaforweigh tloss.com/index.php?option=com content&view=article&id =107:the-fountain-of-youth-has-been-discovered- throughresveratrol- anti-aging&catid=47:resveratrol-study&Itemid =152, Last updated 2009, Accessed on August 13, 2009.
203. Live Healthy Live Longer (2009) Introducing a remarkable product that is so powerful, it could add 25 years to your life and help you feel 25 years younger. http://www. livehealthylivelonger.com/VIVIX Home.hmtl Last updated 2009, Accessed on August 13, 2009.
204. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP,Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD (2008) Ginkgo biloba for Prevention of Dementia: A Randomized Controlled Trial. JAMA 300, 2253-2262.
205. Canter PH, Ernst E (2007) Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Hum Psychopharmacol 22, 265-278.
206. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R (2002) Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288, 835-840.
207. Carlson MC, Saczynski JS, Rebok GW, Seeman T, Glass TA, McGill S, Tielsch J, Frick KD, Hill J, Fried LP (2008) Exploring the effects of an "everyday" activity program on executive function and memory in older adults: Experience Corps. Gerontologist 48, 793-801.
208. Karp A, Paillard-Borg S, Wang HX, Silverstein M, Winblad B, Fratiglioni L (2006) Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord 21, 65-73.
209. BCC Research (2008) Nutraceuticals: Global Markets and Processing, http:/www.bccresearch.com/report/FOD013C. html Last updated 2008, Accessed on August 13, 2009.
210. McDaniel MA, Maier SF, Einstein GO (2003) "Brainspecific" nutrients: a memory cure? Nutrition 19, 957-975.